- £230.91m
- £467.31m
- £72.20m
- 51
- 63
- 57
- 59
C2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 140 | 145 | 73.1 | 73.7 | 72.2 |
Cost of Revenue | |||||
Gross Profit | 89 | 89.8 | 43 | 48.2 | 47.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 162 | 242 | 174 | 48.3 | 75 |
Operating Profit | -21.5 | -97.4 | -101 | 25.4 | -2.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -36.4 | -122 | -123 | 7 | -16.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -36.9 | -121 | -122 | 7 | -16.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -36.9 | -121 | -151 | -26.6 | -16.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -36.9 | -121 | -151 | -26.6 | -16.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.129 | -0.395 | -0.399 | 0.026 | -0.057 |
Dividends per Share |